RetaMaps

Akribis Veins & Vitality: Amanda Cooper, MD

Akribis Veins & Vitality: Amanda Cooper, MD · 121 West Wilson Bridge Road · Worthington, OH 43085

4.8· 116 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Akribis Veins & Vitality is a vein and aesthetics practice in Worthington, Ohio, where its website names Dr. Amanda Cooper, MD, as a board-certified radiologist and vein expert. The site says vein health is where the practice started and lists treatments such as radiofrequency vein ablation, phlebectomy and VenaSeal, along with aesthetic services including non-surgical body sculpting; the listing also shows weight-loss care and hormone care. On Google it has a 4.8-star rating across 116 reviews dating back to 2019, with 9 in the past year. Reviewers mention the staff most of all, in 62 reviews, followed by the providers' knowledge.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.8
Google rating · 116 reviews
9
reviews in the past year (avg ★ 4.6)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-06-02. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.8 across 116 Google reviews. Of the 100 reviews we analyzed, 94 (94%) are positive (4–5★) and 6 (6%) are negative (1–2★).

What patients like

  • Friendly, helpful staff60 reviews
  • Knowledgeable, professional providers29 reviews
  • Feeling listened to21 reviews
  • Weight-loss results16 reviews

Common complaints

  • Billing, pricing or insurance problems3 of 6 negative
  • Scheduling or communication problems3 of 6 negative
  • Staff or front-desk issues2 of 6 negative
5★
94
4★
0
3★
0
2★
1
1★
5

Most recent Google reviews

derik o.★★★★★2026-06-02

I highly recommend! The best support and care you could ask for! Everyone is so polite and truly do care. They remember you, your kids, and all the important details specific to you! They are like family! Dr.Cooper and her staff give 100%. Always.

Anne R.★★★★★2026-04-28

I had an amazing experience with Dr Cooper and her team. Very genuine and kind-Thank you

Katie F.★★★★★2026-03-10

I found Dr. Cooper and her team when I needed vein surgery. The procedure went very well, and each member of the care team was fantastic before, throughout, and following my procedures. I’ve since returned for other services, which have been hugely impactful for my overall health and wellness. My experiences are consistent: they are so welcoming, communicative, thoughtful, and caring. I’ve recommended them highly to others and would certainly continue to do so.

Carol D.★★★★★2026-02-05

Dr. Cooper and staff provided a well informed and comfortable experience for my first rosacea treatment. The office is stunningly appointed and all new state of the art equipment. Dr. Cooper is very meticulous during all of my procedures. I trust her advice and she answers all of my questions. A definite endorsement for her practice!

Sarah P.★★★★★2026-01-16

Dr. Cooper and her staff are thorough, professional and kind.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Clinicians

  • Akribis Veins & Vitality: Amanda Cooper, MD

Nearby providers in Worthington

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs